We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Aggregometer Measures Platelet Function

By HospiMedica staff writers
Posted on 21 Mar 2006
A new aggregometer has been developed that improves detection of abnormal platelet function by using electrical impedence in whole blood or optical density in plasma, while simultaneously measuring adenosine triphosphate (ATP) release by the luminescence method. More...


The new aggregometer 700 is also capable of performing the Ristocetin cofactor assay for diagnosing patients with von Willebrands disease. It was developed by Chrono-log (Havertown, PA, USA) and is distributed by Labmedics (Manchester, UK). Providing accurate results with a fast turnaround time, the whole-blood/luminescence-aggregometer is both a reliable diagnostic tool and a comprehensive screening system. Included with the model 700 are software programs for the platelet aggregation and Ristocetin cofactor assays.

Four samples can be tested at one time with two dual channel modules. Offering an integrated computer interface, the aggregometer has single push-button controls and can be used with disposable or reusable impedance electrodes. The system has luminescence on all channels. The measurement of aggregation together with a secretion study simplifies, speeds, and reduces the cost of platelet function testing. Labmedics offers a range of highly concentrated Chrono-par reagents so that only micro amounts are needed for assays.

The system helps to identify patients at high risk of thrombosis or bleeding, select patients for anti-platelet therapy, as well as monitor treatment.



Related Links:
Chrono-log
Labmedics

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.